Cornerstone Pharmaceuticals is clinical-stage, metabolic oncology therapeutics company.

Biotechnology

Health Care

Pharmaceutical

Cornerstone Pharmaceuticals

Cornerstone Pharmaceuticals' headquarters in Cranbury, NJ, United States

Robert Shorr

Timothy S. Pardee

Jenna Vadas

A. Joseph Stern

Alec Kimmelman

Jorge Cortes

Greg Semenza

Bayard L. Powell

Ariela Noy

Sol J. Barer

Aaron Drillick

Navdeep S. Chandel

J. Randolph Hecht

Josep Tabernero

Craig H. Moskowitz

Heloisa P. Soares

Mikkael Sekeres

Dafna Bar-Sagi

Richard M. Stone

Steven I. Park

Patrick S. Wilmerding

Shmuel Levinger

Howard S. Jonas

Alan B. Rosenthal

Eric Van Cutsem

The Medical Advisors at Cornerstone Pharmaceuticals play a crucial role in bridging the gap between clinical research and practical application by providing expert guidance on metabolic oncology therapeutics. They collaborate with cross-functional teams to develop scientific strategies, support clinical trial designs, and ensure that the medical community is informed about the benefits and developments of innovative therapies. Their insights influence clinical practices and help shape the company’s overall medical strategy.

Medical Advisors

The Scientific Advisors Team at Cornerstone Pharmaceuticals plays a crucial role in guiding the development of metabolic oncology therapies. Comprising seasoned experts, the team collaborates with researchers and clinical staff to provide strategic insights, evaluate scientific data, and ensure that the company’s therapeutic approaches align with the latest advancements in oncology research. Their expertise helps drive innovation and supports the successful progression of clinical trials.

Scientific Advisors Team

The Leadership Team at Cornerstone Pharmaceuticals is responsible for guiding the strategic vision and operational execution of the company’s clinical-stage initiatives in metabolic oncology therapeutics. Comprised of executives with expertise in quality assurance, clinical research, and scientific innovation, the team collaborates to drive product development, ensure regulatory compliance, and foster partnerships that enhance the company’s mission to advance cancer treatment.

Leadership Team

The Research and Development team at Cornerstone Pharmaceuticals focuses on advancing innovative metabolic oncology therapeutics through rigorous scientific research and clinical evaluation. Led by the Chief Scientist and Chief Medical Officer, the team collaborates to design and implement preclinical and clinical studies, ensuring the safety and efficacy of new treatments while adhering to regulatory standards. Their collective expertise drives the discovery and development of groundbreaking therapies aimed at improving patient outcomes in cancer care.

Research and Development

Cornerstone Pharmaceuticals

Org chart

Board & advisors

Teams

Medical Advisors

Scientific Advisors Team

Leadership Team

Research and Development

Offices

Cornerstone Pharmaceuticals

Org chart

Board & advisors

Teams

Medical Advisors

Scientific Advisors Team

Leadership Team

Research and Development

Offices

Related companies